Taking Cancer On through Leading Science

At Boehringer Ingelheim, we are leading scientific discoveries in cancer cell agents, immuno-oncology therapies and their combinations. Together we can – and will – accelerate the delivery of the next 'first' to patients in need. Together with our global family of partners, we are taking cancer on for patients around the world.

Note: This webpage hosts content for general public as well as for  healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right.